Pre‐existing CD95‐based Temra immunity in patients with recurrent/metastatic nasopharyngeal carcinoma predicts response and hyperprogression to dual PD‐L1 and TGFβ inhibition

Authors

Institutions

Publication Details

Journal
Clinical and Translational Medicine
Published
2025-11-01
DOI
https://doi.org/10.1002/ctm2.70535
Primary Topic
Immunotherapy and Immune Responses
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Pre‐existing CD95‐based Temra immunity in patients with recurrent/metastatic nasopharyngeal carcinoma predicts response and hyperprogression to dual PD‐L1 and TGFβ inhibition

Kenneth Sik Kwan Chan, Chi‐Leung Chiang, Wei Dai, Jeffrey Yan Ho Lau et al.
Clinical and Translational Medicine
Immunotherapy and Immune Responses
article

Pre‐existing CD95‐based Temra immunity in patients with recurrent/metastatic nasopharyngeal carcinoma predicts response and hyperprogression to dual PD‐L1 and TGFβ inhibition

Kenneth Sik Kwan Chan, Chi‐Leung Chiang, Wei Dai, Jeffrey Yan Ho Lau, Tai‐Chung Lam, Ngar Woon Kam, Dora L.�W. Kwong, Cho Yiu Lau, Victor Lee Ho Fun
article en

Abstract

No abstract available for this paper.
Clinical and Translational MedicineVol. 15(11)
Chinese University of Hong Kong (HK), University of Hong Kong - Shenzhen Hospital (CN), University of Hong Kong (HK)
Health and Medical Research Fund
Openalex Percentile: Top 62%
Immunotherapy and Immune Responses
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.